In those who have a low compliance for monitoring and persistent risk factors and in subjects with poor symptomatology (silent PAD or CAD), the determination of Cys C and of the Cat S/Cys C ratio might be helpful to predict the probability of polyvascular atherosclerotic disease and low ABI. The gene discussed is CAT; the disease is peripheral arterial disease.